N@N

Andrew Fein Reiterated (BIIB) at Strong Buy and Held Target at $325 on, Jun 12th, 2023

Andrew Fein of HC Wainwright & Co., Reiterated "Biogen Inc." (BIIB) at Strong Buy and Held Target at $325 on, Jun 12th, 2023.

Andrew has made no other calls on BIIB in the last 4 months.

There are 13 other peers that have a rating on BIIB. Out of the 13 peers that are also analyzing BIIB, 3 agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Laura Chico of "Wedbush" Reiterated at Hold and Held Target at $263 on, Tuesday, May 23rd, 2023
• Geoff Meacham of "B of A Securities" Maintained at Hold with Increased Target to $320 on, Thursday, May 4th, 2023
• Steve Chesney of "Atlantic Equities" Maintained at Hold with Decreased Target to $282 on, Wednesday, April 26th, 2023

These are the ratings of the 10 analyists that currently disagree with Andrew

---

• Carter Gould of "Barclays" Maintained at Buy on, Thursday, June 8th, 2023
• Brian Skorney of "Baird" Reiterated at Buy and Held Target at $340 on, Wednesday, June 7th, 2023
• Brian Abrahams of "RBC Capital" Reiterated at Buy and Held Target at $340 on, Friday, June 2nd, 2023
• Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $360 on, Thursday, June 1st, 2023
• Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Increased Target to $350 on, Thursday, May 11th, 2023
• Yatin Suneja of "Guggenheim" Upgraded from Hold to Strong Buy and Increased Target to $350 on, Monday, May 1st, 2023
• Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $371 on, Wednesday, April 26th, 2023
• Matthew Korn of "Morgan Stanley" Maintained at Buy with Decreased Target to $349 on, Wednesday, April 12th, 2023
• Phil Nadeau of "Cowen & Co." Maintained at Buy with Increased Target to $315 on, Thursday, February 16th, 2023
• Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $340 on, Thursday, February 16th, 2023

Contributing Sources

---